Long-term renal function in pediatric liver and heart recipients

Area of Science:

• Nephrology
• Pediatric Transplant Medicine
• Immunosuppression Therapy

Background:

• Long-term pediatric liver and heart transplant survivors are susceptible to progressive renal dysfunction.
• Chronic exposure to calcineurin inhibitors (CNIs) is a primary cause of this renal injury.
• CNI-induced nephrotoxicity can lead to irreversible damage, including afferent arteriopathy, glomerulosclerosis, tubular atrophy, and interstitial fibrosis.

Purpose of the Study:

• To highlight the risk of renal dysfunction in pediatric transplant recipients due to calcineurin inhibitor use.
• To identify risk factors for developing irreversible renal injury.
• To emphasize the need for strategies to minimize CNI exposure and preserve renal function.

Main Methods:

• Review of literature on calcineurin inhibitor nephrotoxicity in pediatric transplant recipients.
• Analysis of risk factors associated with renal compromise.
• Discussion of current screening tools and their limitations.

Main Results:

• 3-6% of pediatric liver and heart transplant recipients develop end-stage renal failure.
• A larger percentage experiences chronic renal insufficiency and hypertension.
• Elevated pre-transplant renal compromise and early post-transplant serum creatinine levels are associated with higher risk.

Conclusions:

• Serum creatinine is an unreliable early marker for CNI-induced renal injury.
• Minimizing long-term calcineurin inhibitor exposure is crucial for reducing renal insufficiency prevalence.
• Proactive management strategies are needed to protect kidney function in this vulnerable pediatric population.